ULBP2–NKG2D signaling in cancer immunity: immune surveillance, immune escape, and therapeutic targeting

UL16-binding protein 2 (ULBP2) is a stress-inducible ligand of natural killer group 2 member D (NKG2D) that connects cellular stress to immune surveillance. Its consequences in cancer depend on membrane accessibility, ligand density, proteolytic shedding, soluble-ligand exposure, duration of stimulation, and effector-cell fitness rather than bulk expression alone. Accessible membrane ULBP2 can support NKG2D–DAP10-dependent natural killer (NK) cell cytotoxicity and CD8 + T-cell costimulation, whereas shedding reduces cell-surface ligand and can generate soluble ULBP2 (sULBP2). Chronic surface-ligand exposure has been associated with NKG2D adaptation in heterologous mouse models; direct human in-vivo validation and quantitative exposure thresholds remain unavailable. In clinical cohorts, associations between circulating sULBP2 and prognosis do not establish that sULBP2 itself mediates immunosuppression. This review distinguishes ULBP2-specific observations from pan-NKG2D-ligand findings and platform-based extrapolations. It critically evaluates molecular regulation, immune activation and escape, biomarker assays, and CAR-based therapies, multispecific engagers, antibodies, and antibody–drug conjugates (ADCs). EVOLVE104 recognizes ULBP2/5/6 and is under phase I investigation, but the available public sources contain no mature clinical efficacy or safety outcomes; ULBP2-specific CAR-T approaches remain preclinical and ULBP2-directed ADCs lack target-developability validation. Translation will require matched measurements of surface ULBP2 and sULBP2, human-relevant normal-tissue testing, functional immune readouts, and construct-specific assessment of target selectivity, internalization, and exposure.

Authors

Institutions

Publication Details

Journal
Frontiers in Immunology
Published
2026-11-16
DOI
https://doi.org/10.3389/fimmu.2026.2012358
Primary Topic
Immune Cell Function and Interaction
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

ULBP2–NKG2D signaling in cancer immunity: immune surveillance, immune escape, and therapeutic targeting

Haobo Han, Weiwen Cai, Ruohan Ma, Biao Ding et al.
4 links
Frontiers in Immunology
Immune Cell Function and Interaction
article

ULBP2–NKG2D signaling in cancer immunity: immune surveillance, immune escape, and therapeutic targeting

Haobo Han, Weiwen Cai, Ruohan Ma, Biao Ding, 焦作义, Long Qin
article en

Abstract

UL16-binding protein 2 (ULBP2) is a stress-inducible ligand of natural killer group 2 member D (NKG2D) that connects cellular stress to immune surveillance. Its consequences in cancer depend on membrane accessibility, ligand density, proteolytic shedding, soluble-ligand exposure, duration of stimulation, and effector-cell fitness rather than bulk expression alone. Accessible membrane ULBP2 can support NKG2D–DAP10-dependent natural killer (NK) cell cytotoxicity and CD8 + T-cell costimulation, whereas shedding reduces cell-surface ligand and can generate soluble ULBP2 (sULBP2). Chronic surface-ligand exposure has been associated with NKG2D adaptation in heterologous mouse models; direct human in-vivo validation and quantitative exposure thresholds remain unavailable. In clinical cohorts, associations between circulating sULBP2 and prognosis do not establish that sULBP2 itself mediates immunosuppression. This review distinguishes ULBP2-specific observations from pan-NKG2D-ligand findings and platform-based extrapolations. It critically evaluates molecular regulation, immune activation and escape, biomarker assays, and CAR-based therapies, multispecific engagers, antibodies, and antibody–drug conjugates (ADCs). EVOLVE104 recognizes ULBP2/5/6 and is under phase I investigation, but the available public sources contain no mature clinical efficacy or safety outcomes; ULBP2-specific CAR-T approaches remain preclinical and ULBP2-directed ADCs lack target-developability validation. Translation will require matched measurements of surface ULBP2 and sULBP2, human-relevant normal-tissue testing, functional immune readouts, and construct-specific assessment of target selectivity, internalization, and exposure.

Frontiers in ImmunologyVol. 17
Lanzhou University Second Hospital (CN), Lanzhou University (CN)
National Natural Science Foundation of China
Good health and well-being
Immune Cell Function and Interaction
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon